Hormonal, reproductive, and lifestyle risk factors, pedigree-level family history information, breast density, breast tumor pathology, and genetic testing results on rare P/LP variants in high- and moderate-risk genes (BRCA1, BRCA2, PALB2, CHEK2, and ATM), besides PRS313. This evidence concerns the gene BRCA1 and breast neoplasm.